As of January 22, 2025, Jamjoom Pharmaceuticals Factory Company (4015.SR) has a market cap of $3.09 billion USD. According to our data, Jamjoom Pharmaceuticals Factory Company is ranked No.3449 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $3.09 B |
8.94%
|
Dec 31, 2024 | $2.84 B |
35.11%
|
Dec 31, 2023 | $2.10 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Pfizer
PFE
|
$148.34 B |
-0.006 M
|
USA
|
Johnson & Johnson
JNJ
|
$347.78 B |
-0.005 M
|
USA
|
Merck
MRK
|
$242.59 B |
0.007 M
|
USA
|
Novartis
NVS
|
$197.43 B |
0.007 M
|
Switzerland
|
GlaxoSmithKline
GSK
|
$68.38 B |
0.002 M
|
UK
|
Sanofi
SNY
|
$128.55 B |
0.003 M
|
France
|
AstraZeneca
AZN
|
$211.43 B |
0.005 M
|
UK
|
AbbVie
ABBV
|
$300.53 B |
0.002 M
|
USA
|
Bristol-Myers Squibb
BMY
|
$115.86 B |
0.003 M
|
USA
|
Eli Lilly
LLY
|
$676.92 B |
0.020 M
|
USA
|
Amgen
AMGN
|
$147.53 B |
0.002 M
|
USA
|
Teva Pharmaceutical Industries
TEVA
|
$25.08 B |
19.908 M
|
Israel
|
Takeda Pharmaceutical
TAK
|
$41.01 B |
-0.002 M
|
Japan
|
Market Cap | = | 4015.SR Stock Price | * | 4015.SR Shares Outstanding |
= | $44.20 | * | 70.00 M | |
= | $3.09 B |